The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis.

Source:http://linkedlifedata.com/resource/pubmed/id/16000952

Download in:

View as

General Info

PMID
16000952